Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2007
11/07/2007CN101066278A Medicine use of energy mixture
11/07/2007CN100347306C Method and means for producing protein with prospective post-translation modification
11/07/2007CN100347297C Process for producing human thrombin by gene modification technique
11/07/2007CN100347193C Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant
11/07/2007CN100347192C Collagen and method for producing same
11/07/2007CN100347191C 新mhcⅱ相关肽 New mhcⅱ related peptide
11/07/2007CN100347187C Process for preparing anticencer active protein of thick muzzle syngnathus
11/07/2007CN100346834C Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene theraphy
11/07/2007CN100346828C Immunogenic compositions
11/07/2007CN100346823C Enamel matrix protein compositions for modulating immune response
11/07/2007CN100346822C Leukocyte inactivation module
11/07/2007CN100346805C Application of shinyleaf yellowhorn fruit shell in preparing cerbral function improving food and medicine
11/07/2007CN100346767C Composite powders and skin preparations for external use containing the same
11/06/2007US7291723 Hepatitis G viral sequences for use as heterologous gene transfer tool; vaccine development; viricides
11/06/2007US7291717 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
11/06/2007US7291716 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2007US7291715 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
11/06/2007US7291714 A non-human antibody or fragment that specifically binds to a platelet membrane glycoprotein that is involved platelet-collagen interactions
11/06/2007US7291713 For modifying polypeptides
11/06/2007US7291709 LSR (Lipolysis Stimulated Receptor); for the prevention and/or treatment of pathologies and/or of pathogeneses such as obesity and anorexia, hyperlipidemias, atherosclerosis, diabetes, hypertension
11/06/2007US7291708 PRO1785 polypeptides
11/06/2007US7291706 PRO4352 polypeptides
11/06/2007US7291704 PRO1758 polypeptides
11/06/2007US7291703 PRO1508 polypeptides
11/06/2007US7291702 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
11/06/2007US7291700 PRO4985 polypeptide
11/06/2007US7291699 polypeptides, fragments and/or amino acid sequences having replacements, deletions or inserts, used to promote myoblast activation, growth or regeneration
11/06/2007US7291673 Polymeric biomaterials formed by nucleophilic addition reactions to conjugated unsaturated groups
11/06/2007US7291650 Breast cancer ; therapy containing plant extracts
11/06/2007US7291635 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents
11/06/2007US7291619 Melanocortin receptor agonists
11/06/2007US7291605 Methods of treating various cancers using melanoma differentiation associated protein-7
11/06/2007US7291604 Administering to tissue, such as blood vessel and active nucleic acids ; insertion of stents; cardiovascular disorders
11/06/2007US7291601 Arginine-rich anti-vascular endothelial growth factor peptides that inhibit growth and metastasis of human tumor cells by blocking angiogenesis
11/06/2007US7291600 Non-T cell binding peptides and their uses
11/06/2007US7291599 Such as amistatin and leuhistin; for control of inflammation; topical creams, gels, ointments
11/06/2007US7291598 Nanoparticles for protein drug delivery
11/06/2007US7291597 Growth factor therapy mobilization of stem cells into the peripheral blood
11/06/2007US7291596 For activating the non-proteolytically activated thrombin receptor
11/06/2007US7291595 Administering to the patient about 15 to about 360 mg of alpha-1-antitrypsin per kg patient body mass, and repeating the administration at least once with a periodicity of between 3 and 31 days
11/06/2007US7291594 Human glucagon-like peptide-1 (GLP-1) derivatives absorbed highly via a mucous membrane in the oral cavity, lung, nose or intestines; for therapy of non-insulin dependent diabetes muellitus, insulin dependent diabetes mellitus and/or obesity
11/06/2007US7291593 Administering follicle stimulating hormone (FSH) at an initial dose in the range of from 100 to 600 IU followed by a second dose at least 3 days later in the stimulation phase for therapy of infertility in women
11/06/2007US7291592 Method for treating patients with massive blood loss
11/06/2007US7291591 Alcohol-free transdermal insulin composition
11/06/2007US7291590 Compositions and methods for treating atherosclerosis
11/06/2007US7291589 using Zven1 and Zven2 polypeptides to increase chemokine production for treating intestinal motility disorders and improving gastrointestinal funciton
11/06/2007US7291588 Immunogenic detoxified mutant E. coli LT-A toxin
11/06/2007US7291587 Useful for treating bleeding episodes due to trauma, surgery, lowered count or activity of platelets
11/06/2007US7291495 β-Secretase variant
11/06/2007US7291494 Comprises (iso)peptidases; proteasomes; drug screening; for treatment of cancer, inflammation, asthma, ischemia, arthritis, and/or psoriasis
11/06/2007US7291462 TADG-15: an extracellular serine protease overexpressed in carcinomas
11/06/2007US7291458 Leptin-mediated gene-induction
11/06/2007US7291451 Modulation of pericyte proliferation
11/06/2007US7291344 Administering a botulinum toxin
11/06/2007US7291343 Therapy for antibiotic resistance; immunotherapy
11/06/2007US7291341 in the recovery phase of stress responses, as an anti-inflammatory agent, as a cardioprotective agent, and in the treatment of psychiatric and anxiolytic disorders
11/06/2007US7291339 Chimeric polypeptide comprising bifunctional activities for use in medical diagnostics and monitoring protein interaction
11/06/2007US7291337 Stable envelope protein; human t-cell leukemia, lymphoma viruses
11/06/2007US7291336 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
11/06/2007US7291335 Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof
11/06/2007US7291334 antibodies that bind to immunogens for diagnosis of enterotoxigenic E. coli infections such as traveler's diarrhea; kits
11/06/2007US7291333 Blockade of protein C activation reduces microvascular surgical blood loss
11/06/2007US7291332 Inflammatory mediator antagonists
11/06/2007US7291330 MD-1 inhibitors as immune suppressants
11/06/2007US7291329 Antibodies against PRO4406
11/06/2007US7291165 Medical device for delivering biologically active material
11/06/2007CA2385538C Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars
11/06/2007CA2363713C Lantibiotic
11/06/2007CA2307343C Inducible cellular immunity through activation of th1 and suppression of th2 responses by macrophages
11/06/2007CA2206599C Method and device for separating fibrin i from blood plasma
11/06/2007CA2202058C Cyclic hexapeptides having antibiotic activity
11/06/2007CA2182795C Superactive vip antagonists
11/06/2007CA2126639C Milk protein partial hydrolysate and process for preparation thereof
11/06/2007CA2114251C Igf-1 to improve the neural condition
11/06/2007CA2113089C Universal donor cells
11/06/2007CA2079881C Nucleotidic sequences coding for variable regions of .beta. chains of human t lymphocite receptors, corresponding peptidic segments and diagnostic and therapeutic applications
11/06/2007CA2079879C Nucleotidic sequences coding for alpha chain variable regions in human lymphocite receptors and applications thereof
11/06/2007CA2010058C Storage of materials
11/01/2007WO2007124486A2 Bmp4 inhibitors
11/01/2007WO2007124354A2 Use of tight junction agonists to facilitate pulmonary delivery of therapeutic agents
11/01/2007WO2007124198A2 Biopolymer system for tissue sealing
11/01/2007WO2007124133A2 Methods and compositions based on shiga toxin type 1 protein
11/01/2007WO2007123955A2 Stable hydroalcoholic oral spray formulations and methods
11/01/2007WO2007123872A2 Polyesteramide platform for site specific drug delivery
11/01/2007WO2007123848A2 Therapeutic compositions containing modified class i slrp proteins
11/01/2007WO2007123847A2 Treatment of melanoma
11/01/2007WO2007123777A2 Inhibition of hif-1 activation for anti-tumor and anti-inflammatory responses
11/01/2007WO2007123765A2 Neutrokine-alpha and neutrokine-alpha splice variant
11/01/2007WO2007123723A2 Diagnosis and treatment of alzheimer's disease
11/01/2007WO2007123691A2 Method for treating blood coagulation disorders
11/01/2007WO2007123672A2 Cytokine-expressing cancer immunotherapy combinations
11/01/2007WO2007123402A2 Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene
11/01/2007WO2007123391A1 Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly expressed gene.
11/01/2007WO2007123200A1 Composition containing peptide as the active ingredient
11/01/2007WO2007123010A1 Agent for improving bone metabolism
11/01/2007WO2007122976A1 Therapeutic agent or development inhibitor of polyglutamine disease
11/01/2007WO2007122975A1 Hgf precursor protein mutant and activated form thereof
11/01/2007WO2007122885A1 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator
11/01/2007WO2007122622A1 Method of treatment of a disease
11/01/2007WO2007122423A1 Larval enzymes
1 ... 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 ... 3163